T1 Protein 1444 1457 GERD symptoms
T2 Intervention 71 83 oesophageal 
T3 Condition 452 454 OA
T4 Condition 87 133  and oesophagogastric junction adenocarcinomas
T5 Protein 1186 1199 GERD symptoms
T6 Condition 1055 1057 OA
T7 Condition 1374 1378  OA 
T8 Condition 700 704  OA 
T9 Biomarker 714 742 Random-effects meta-analysis
T10 Protein 708 712 OGJA
T11 Organism 339 350 participant
T12 Condition 451 455  OA 
T13 Condition 1570 1572 OA
T14 Organism 1400 1403 men
T15 Protein 1382 1386 OGJA
T16 Condition 701 703 OA
T17 Condition 1569 1573  OA 
T18 Condition 59 66 obesity
T19 Protein 855 868 GERD symptoms
T20 Condition 1293 1295 OA
T21 Condition 233 240 obesity
T22 Protein 1090 1094 OGJA
T23 Protein 1264 1277 GERD symptoms
T24 Condition 84 86 OA
T25 Protein 135 139 OGJA
T27 Condition 1375 1377 OA
T28 Protein 914 918 OGJA
T29 Protein 1577 1581 OGJA
T30 Intervention 656 660 body
T31 Condition 906 910  OA 
T32 Condition 907 909 OA
T33 Condition 1054 1058  OA 
T34 Intervention 285 297 oesophageal 
T35 Protein 1296 1300 OGJA
T36 Organism 1408 1413 women
T37 Protein 467 471 OGJA
R1 Relation Arg1:T3 Arg2:T37
R2 Relation Arg1:T12 Arg2:T37
